Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 26607
IPSCIO Record ID: 27353
U.S. Patent No. 5,460,830 entitled 'Biochemically Active Agents for Chemical Catalysis and Cell Receptor Activation', U.S. Patent No. 5,460,831 entitled 'Targeted Transfection Nanoparticles', U.S. Patent No. 5,462,750 entitled 'Biologically Active Compositions Having a Nanocrystalline Core', U.S. Patent No. 5,462,751 entitled 'Biological and Pharmaceutical Agents Having a Nanomeric Biodegradable Core' and U.S. Patent No. 5,464,634 entitled 'Red Blood Cell Surrogate'.
IPSCIO Record ID: 282943
Licensee grants to Licensor and Licensor accepts, as from the Effective Date, an exclusive, unlimited, world-wide, perpetual, royalty-free license, with the right to grant sub-licenses to make, use, sell, market and develop any PolyActive Rights B relating to osseouschondral and/or osteochondral plugs, fillers, cement restrictors, or the like, including but not limited to SynPlug(TM) (Licensee License B.)
Licensee grants to Licensor and Licensor accepts, as from the Effective Date, an exclusive, unlimited, world-wide, perpetual, royalty-free license, with the right to grant sub-licenses to make, use, sell, market and develop any PolyActive Rights A and/or PolyActive Rights B related to the use of the PolyActive Technology in a medical device to be used to measure and/or monitor blood glucose (Licensor License AB).
PolyActive shall mean a biodegradable (amphiphilic) poly(ether-ester) multiblock copolymer based on PEGT and PBT.
CHIENNA-Patents shall mean the patents and patent applications defined and listed in Annex I(A) to the ACLA.
PolyActive Rights A shall mean the PolyActive Rights A as defined and listed in Annex 3.2, consisting of the CHIENNA-Patents but not including all previously abandoned and/or transferred patents and patent applications.
6,685,957 – Preparation of fibrous polymer implant containing bioactive agents using wet spinning technique
5,980,948 – Polyetherester copolymers as drug delivery matrices
PolyActive Rights B Shall mean the PolyActive Rights B as defined and listed in Annex 3.1, consisting of the Licensor-Patents but not including (1) all previously abandoned and/or transferred patents and patent applications; (2) the Osteoinduction patent family; and (3) the Cement Restrictor 4th Design.
6,479,418 – Porous ceramic body
6,069,295 – Implant material
Locteron is a controlled release formulation of interferon alfa for the treatment of chronic hepatitis C, currently in Phase IIa studies.
Orthopedic Field shall mean that part of the Licensees patents and patent application which relate to a therapeutic application to the musculoskeletal system, including bone, cartilage, joints, related connective tissues, ligaments, tendons and nerves.
PolyActive technology and its intellectual property in certain strategic areas, including additional applications in orthopedics.